Viral endomyocardial infection is an independent predictor and potentially treatable risk factor for graft loss and coronary vasculopathy in pediatric cardiac transplant recipients

Journal of the American College of Cardiology

Volumn 56, Issue 7, 2010, Pages 582-592

  Moulik, Mousumi ^a   Breinholt, John P ^b   Dreyer, William J ^c   Kearney, Debra L ^c   Price, Jack F ^c   Clunie, Sarah K ^c   Moffett, Brady S ^c   Kim, Jeffrey J ^c   Rossano, Joseph W ^c   Jefferies, John Lynn ^c   Bowles, Karla R ^d   O'Brian Smith, E ^c   Bowles, Neil E ^e   Denfield, Susan W ^c   Towbin, Jeffrey A ^f  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TEXAS CHILDREN S HOSPITAL   (United States)

^d Utah   (United States)

^e UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^f CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

acute rejection; AR; CMV; cytomegalovirus; EBV; EMB; endomyocardial biopsy; Epstein Barr virus; International Society of Heart and Lung Transplantation; intravenous immunoglobulin; ISHLT; IVIG; PCR; polymerase chain reaction; TCAD; transplant coronary artery disease

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ACUTE GRAFT REJECTION; ADENOVIRUS; ADOLESCENT; ADULT; ARTICLE; CARDIAC GRAFT REJECTION; CHILD; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CYTOMEGALOVIRUS; DRUG WITHDRAWAL; ENTEROVIRUS; EPSTEIN BARR VIRUS; FEMALE; GENETIC SCREENING; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; HUMAN PARVOVIRUS B19; HUMAN TISSUE; INFANT; INFECTION RISK; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREDICTION; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE DRUG DOSE; SURVIVAL TIME; TREATMENT OUTCOME; VIRUS GENOME; VIRUS MYOCARDITIS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CORONARY DISEASE; FEMALE; GENOME, VIRAL; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; MYOCARDITIS; POLYMERASE CHAIN REACTION; PREVALENCE; RISK FACTORS;

EID: 77955614684     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.02.060     Document Type: Article

References (28)

1. W.H. Barker, J.P. Mullooly, and W. Getchell Changing incidence and survival for heart failure in a well-defined older population, 1970-1974 and 1990-1994 Circulation 113 2006 799 805
2. D.O. Taylor, L.B. Edwards, and M.M. Boucek, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult heart transplant report - 2005 J Heart Lung Transplant 24 2005 945 955
3. M.M. Boucek, L.B. Edwards, B.M. Keck, E.P. Trulock, D.O. Taylor, and M.I. Hertz Registry of the International Society for Heart and Lung Transplantation: eighth official pediatric report - 2005 J Heart Lung Transplant 24 2005 968 982
4. N.E. Bowles, P.J. Richardson, E.G. Olsen, and L.C. Archard Detection of Coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy Lancet 1 1986 1120 1123
5. U. Kuhl, M. Pauschinger, and B. Seeberg, et al. Viral persistence in the myocardium is associated with progressive cardiac dysfunction Circulation 112 2005 1965 1970
6. H.T. Aretz, M.E. Billingham, and W.D. Edwards, et al. Myocarditis A histopathologic definition and classification Am J Cardiovasc Pathol 1 1987 3 14
7. M.E. Billingham, N.R. Cary, and M.E. Hammond, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group The International Society for Heart Transplantation J Heart Transplant 9 1990 587 593
8. K.O. Schowengerdt, J. Ni, and S.W. Denfield, et al. Diagnosis, surveillance, and epidemiologic evaluation of viral infections in pediatric cardiac transplant recipients with the use of the polymerase chain reaction J Heart Lung Transplant 15 1996 111 123
9. F. Douche-Aourik, T. Bourlet, and J.F. Mosnier, et al. Association between enterovirus endomyocardial infection and late severe cardiac events in some adult patients receiving heart transplants J Med Virol 75 2005 47 53
10. K.O. Schowengerdt, J. Ni, and S.W. Denfield, et al. Association of parvovirus B19 genome in children with myocarditis and cardiac allograft rejection: diagnosis using the polymerase chain reaction Circulation 96 1997 3549 3554
11. G.S. Shirali, J. Ni, and R.E. Chinnock, et al. Association of viral genome with graft loss in children after cardiac transplantation N Engl J Med 344 2001 1498 1503
12. N.D. Bridges, T.L. Spray, M.H. Collins, N.E. Bowles, and J.A. Towbin Adenovirus infection in the lung results in graft failure after lung transplantation J Thorac Cardiovasc Surg 116 1998 617 623
13. E. Ramos, C.B. Drachenberg, and J.C. Papadimitriou, et al. Clinical course of polyoma virus nephropathy in 67 renal transplant patients J Am Soc Nephrol 13 2002 2145 2151
14. M. Smieja, J. Gnarpe, and E. Lonn, et al. Multiple infections and subsequent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study Circulation 107 2003 251 257
15. M.T. Grattan, C.E. Moreno-Cabral, V.A. Starnes, P.E. Oyer, E.B. Stinson, and N.E. Shumway Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis JAMA 261 1989 3561 3566
16. P.K. Koskinen, M.S. Nieminen, and L.A. Krogerus, et al. Cytomegalovirus infection and accelerated cardiac allograft vasculopathy in human cardiac allografts J Heart Lung Transplant 12 1993 724 729
17. H.A. Valantine, S.Z. Gao, and S.G. Menon, et al. Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study Circulation 100 1999 61 66
18. H.A. Valantine, H. Luikart, and R. Doyle, et al. Impact of cytomegalovirus hyperimmune globulin on outcome after cardiothoracic transplantation: a comparative study of combined prophylaxis with CMV hyperimmune globulin plus ganciclovir versus ganciclovir alone Transplantation 72 2001 1647 1652
19. N.A. Drucker, S.D. Colan, and A.B. Lewis, et al. Gamma-globulin treatment of acute myocarditis in the pediatric population Circulation 89 1994 252 257
20. D.M. McNamara, W.D. Rosenblum, and K.M. Janosko, et al. Intravenous immune globulin in the therapy of myocarditis and acute cardiomyopathy Circulation 95 1997 2476 2478
21. M.D. Kazatchkine, and S.V. Kaveri Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin N Engl J Med 345 2001 747 755
22. A. Sener, A.A. House, and A.M. Jevnikar, et al. Intravenous immunoglobulin as a treatment for BK virus associated nephropathy: one-year follow-up of renal allograft recipients Transplantation 81 2006 117 120
23. H.A. McAllister Jr. Histologic grading of cardiac allograft rejection: a quantitative approach J Heart Transplant 9 1990 277 282
24. M.R. Costanzo, D.C. Naftel, and M.R. Pritzker, et al. Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors Cardiac Transplant Research Database J Heart Lung Transplant 17 1998 744 753
25. E. Pahl, D.C. Naftel, and M.A. Kuhn, et al. The impact and outcome of transplant coronary artery disease in a pediatric population: a 9-year multi-institutional study J Heart Lung Transplant 24 2005 645 651
26. U. Kuhl, M. Pauschinger, and M. Noutsias, et al. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction Circulation 111 2005 887 893
27. U. Kuhl, M. Pauschinger, and P.L. Schwimmbeck, et al. Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction Circulation 107 2003 2793 2798
28. M. Noutsias, M. Pauschinger, W.C. Poller, H.P. Schultheiss, and U. Kuhl Immunomodulatory treatment strategies in inflammatory cardiomyopathy: current status and future perspectives Expert Rev Cardiovasc Ther 2 2004 37 51